Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hasselblatt

Showing results (111-120 of 232) with videos related to

Pageof 24
Sort By:
Neuropathology and Applied Neurobiology|August 30, 2021
A malignant choroid plexus tumour with prevailing immature blastematous elementsArnault Tauziède-Espariat, Mélanie Pagès, Julien Masliah-Planchon, et al.
Biochemical and Biophysical Research Communications|August 1, 2006
Nitric oxide synthase is up-regulated in muscle fibers in muscular dystrophyKarla Punkt, Stefan Schering, Sabine Löffler, et al.
The American Journal of Surgical Pathology|May 14, 2011
Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expressionMartin Hasselblatt, Stefan Gesk, Florian Oyen, et al.
Genes, Chromosomes & Cancer|October 18, 2012
High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumorsMartin Hasselblatt, Sarah Isken, Anna Linge, et al.
Journal of Neuro-Oncology|January 17, 2009
Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAILDolly G Aguilera, Chandra M Das, Neeta D Sinnappah-Kang, et al.
American Journal of Human Genetics|February 9, 2010
Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndromeReinhard Schneppenheim, Michael C Frühwald, Stefan Gesk, et al.
International Journal of Cancer|July 1, 2010
Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastomaJanna Paulsson, Maja Bradic Lindh, Malin Jarvius, et al.
Neuro-Oncology|September 17, 2024
Constitutional mosaicism of pathogenic variants in SMARCB1 in a subset of patients with sporadic rhabdoid tumorsLara S Fleischmann, Karolina Nemes, Selina Glaser, et al.
Journal of Neuro-Oncology|July 10, 2012
DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysisAndré O von Bueren, Joachim Gerss, Christian Hagel, et al.
Acta Neuropathologica Communications|October 31, 2025
A rare case of atypical teratoid rhabdoid tumor (AT/RT) with homozygous SMARCB1 loss and one concurrent somatic heterozygous SMARCA4 variantYlvi Müller, Sebastian Bühner, Victoria Fincke, et al.
Pageof 24

Showing results (111-120 of 232) with videos related to

Sort By:
Pageof 24
Neuropathology and Applied Neurobiology|August 30, 2021
A malignant choroid plexus tumour with prevailing immature blastematous elementsArnault Tauziède-Espariat, Mélanie Pagès, Julien Masliah-Planchon, et al.
Biochemical and Biophysical Research Communications|August 1, 2006
Nitric oxide synthase is up-regulated in muscle fibers in muscular dystrophyKarla Punkt, Stefan Schering, Sabine Löffler, et al.
The American Journal of Surgical Pathology|May 14, 2011
Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expressionMartin Hasselblatt, Stefan Gesk, Florian Oyen, et al.
Genes, Chromosomes & Cancer|October 18, 2012
High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumorsMartin Hasselblatt, Sarah Isken, Anna Linge, et al.
Journal of Neuro-Oncology|January 17, 2009
Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAILDolly G Aguilera, Chandra M Das, Neeta D Sinnappah-Kang, et al.
American Journal of Human Genetics|February 9, 2010
Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndromeReinhard Schneppenheim, Michael C Frühwald, Stefan Gesk, et al.
International Journal of Cancer|July 1, 2010
Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastomaJanna Paulsson, Maja Bradic Lindh, Malin Jarvius, et al.
Neuro-Oncology|September 17, 2024
Constitutional mosaicism of pathogenic variants in SMARCB1 in a subset of patients with sporadic rhabdoid tumorsLara S Fleischmann, Karolina Nemes, Selina Glaser, et al.
Journal of Neuro-Oncology|July 10, 2012
DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysisAndré O von Bueren, Joachim Gerss, Christian Hagel, et al.
Acta Neuropathologica Communications|October 31, 2025
A rare case of atypical teratoid rhabdoid tumor (AT/RT) with homozygous SMARCB1 loss and one concurrent somatic heterozygous SMARCA4 variantYlvi Müller, Sebastian Bühner, Victoria Fincke, et al.
Pageof 24